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Diabetic blindness is a preventable condition. 
Unfortunately diabetic screening and early inter-
vention are not yet available for most of the diabetic 
population in the state sector in South Africa (SA). 
A recent review of 248 diabetic patients attending 
a day hospital in Cape Town revealed that only 5.2% had regular 
annual fundus examinations and only 10.4% were aware that annual 
fundoscopy was required.[1] Although screening programmes have 
been piloted or partially implemented in a few localised centres,[2,3] 
the severe deficiencies in current screening and laser management 
mean that large numbers of patients present with advanced ocu-
lar complications of diabetes. Management of these patients usu-
ally requires surgical intervention (vitrectomy), and visual outcomes 
remain unpredictable.
Fifty per cent of vitrectomies performed at Groote Schuur Hospital 
(GSH), Cape Town, are for the complications of diabetic retinopathy, and 
we anticipate that the proportion may be similar at other state hospitals. 
In resource-limited settings it is appropriate to examine the outcomes of 
retinal surgery and to assess context-specific risk factors that may influence 
surgical outcomes, as well as decisions affecting resource allocation. We are 
not aware of any publications of this type from SA state facilities.
Methods
We performed a retrospective cohort study of consecutive patients 
undergoing diabetic vitrectomy at GSH from January 2012 to 
December 2012 with up to 6 months’ follow-up. All patients were 
assessed and listed for surgery by four vitreoretinal consultants 
(one full-time and three sessional consultants) and one trainee 
vitreoretinal consultant in the department. Preoperative visual 
acuities were recorded using Snellen charts. The time from listing 
for surgery to the date of the operation was recorded, as well as any 
change in visual acuity during this period. Surgical cancellations or 
postponements were recorded. Routine preoperative tests included 
an assay for urea and electrolytes.
Intraoperative details were recorded by each surgeon. Early (within 
1 month) and late postoperative complications were noted. If silicone 
oil was inserted during the procedure, time until removal of oil was 
recorded. Postoperative visual acuity was assessed at 3 and 6 months, 
and cases were considered anatomical successes if the retina was 
completely attached with no features of proliferation in the absence 
of a tamponading agent (e.g. silicone oil).
All data were collected in Epidata and transferred to STATA 12 
(Stata Statistical Software: Release 12, StataCorp, USA) for analysis. 
Visual acuity was converted to the logarithm of the minimum angle 
of resolution (LogMAR) for statistical analysis. The χ2 test or Fisher’s 
exact test was used for categorical variables and Student’s t-test and 
the rank sum test for continuous variables. Logistic regression was 
used to examine prognostic factors.
The study was approved by the University of Cape Town Human 
Research Ethics Committee (approval number: HREC 851/2014).
Results
During the study period, 124 vitrectomies were performed on 
115 patients, 18 (15.6%) of whom were from rural areas. Seventy-
one (61.7%) were female. The mean age at surgery was 57 years. 
Indications for surgery are listed in Table 1.
Visual acuity was LogMAR 1.0 (Snellen 6/60) or worse in the better 
eye in 23.4% of patients at presentation. At the time of listing for 
surgery, the mean visual acuity of the involved eye was LogMAR 1.45 
(Snellen 2/60). Sixty eyes (48.8%) were classified as counting fingers 
or worse. Three patients had perception of light only (Table 2). The 
patient’s fellow eye was considered inoperable in 20.2% of cases.
The average waiting time until surgery was 2.9 months (range 
1 day - 9 months) (Fig. 1). During this time 26.2% of eyes experienced 
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a worsening of visual acuity, dropping from a mean of LogMAR 0.84 
to LogMAR 1.84 (Snellen 6/40 to <1/60; p<0.0001). One patient 
dropped from 6/24 to perception of light only (Fig. 2).
Surgery was cancelled or postponed at least once in 15 cases 
(12.1%). The most common reasons for cancellation were shortage 
of surgery time on the day (n=7) and poor systemic health with high 
anaesthetic risk (n=6). In 54 cases (43.5%) estimated glomerular 
filtration rates revealed moderate renal dysfunction or worse at the 
time of surgery; nine patients had severe renal dysfunction and two 
renal failure.
All surgeries were performed using the Constellation Vision System 
(Alcon Laboratories). Surgery was performed by one full-time consultant, 
three part-time consultants and one trainee vitreoretinal consultant. 
Fifty-one per cent of procedures were performed using 23-gauge, 48.4% 
using 20-gauge and 0.8% using 25-gauge instrumentation. Cataract 
surgery was performed at the same time in 54.0% of cases. Epiretinal 
membranes were present in 93.6% of patients and any degree of macular 
traction in 79.0%. Posterior iatrogenic retinal breaks occurred in 49.2% 
of cases and port-related tears in 7.8%.
To achieve intraocular tamponade, silicone oil was used in 24.2% 
of cases, SF6 gas in 23.4%, C3F8 gas in 7.3%, and air in 7.3%; in 37.9% 
no tamponade was necessary. Of the patients in whom silicone oil 
was used (30 cases), 6 (20.0%) had significant haemorrhage under 
the oil in the early postoperative period. The mean duration of time 
until the silicone oil was removed was 9.9 months (range 5.3 - 16.8).
Raised intraocular pressure (>21 mmHg) was the most common 
early postoperative complication (43.6%), which persisted in 13.1% of 
cases at 1 month. A fibrinoid anterior chamber reaction was observed 
in 20.9% of cases in which cataract surgery was done at the same time 
as vitrectomy, compared with only 5.3% of those without concurrent 
cataract surgery (p=0.02). In 8.0% of cases reoperation was required 
for residual subretinal fluid or postoperative vitreous haemorrhage. 
Anatomical success, defined as an attached retina without tamponade 
and non-progressive diabetic retinopathy, was achieved in 77.1% of 
cases.
Information on visual acuity was available for 113 cases (91.1%) 
at 3 months and for 93 (75.0%) at 6 months. The mean LogMAR 
acuity was 1.01 (Snellen 6/60) at 3 months and 0.85 (Snellen 6/40) 
at 6 months, demonstrating a statistically significant improvement 
(p=0.01). Visual acuity was improved (by at least 0.3 LogMAR units, 
n=51) in 54.9%, unchanged (within 0.3 LogMAR units, n=28) in 
30.1% and worse (by at least 0.3 LogMAR units, n=13) in 14.0% of 
cases at 6 months. Four eyes had no perception of light at 6 months 
secondary to neovascular glaucoma (Fig. 3).
In our study, the odds of improved vision at 6 months was statistically 
related to worse visual acuity at the time of surgery (odds ratio (OR) 
Table 1. Indications for surgery
Indication n (%)
Non-clearing vitreous haemorrhage 21 (16.9)
Tractional retinal detachment affecting the macula 37 (29.8)
CTR 20 (16.1)
Macular traction and vitreous haemorrhage 43 (34.7)
Other 3 (2.4)
Total 124
CTR = combined tractional rhegmatogenous retinal detachment.
Table 2. Presenting visual acuity of the operated eye
LogMAR acuity Snellen equivalent n (%)
0.18 6/9 4 (3.3)
0.3 6/12 4 (3.3)
0.48 6/18 19 (15.5)
0.6 6/24 9 (7.3)
0.78 6/36 8 (6.5)
1.0 6/60 18 (14.6)
1.3 3/60 1 (0.8)
2.0 CF 39 (31.7)
3.0 HM 18 (14.6)
5.0 PL 3 (2.4)
Total 123 (100.0)
CF = count fingers; HM = hand motions; PL = perception of light. 
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Fig. 1. Waiting time for surgery.
Fig. 2. Change in visual acuity while awaiting surgery (logarithmic scale). 
(CF = count fingers; HM = hand motions; PL = perception of light.)
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2.15; p=0.048). Older age at surgery was associated with a reduced 
likelihood of visual improvement at 6 months (OR 0.92; p=0.042). Poor 
vision in the other eye (counting fingers or worse) did not increase 
the risk of poor visual outcome (p=0.58). Avoiding iatrogenic retinal 
breaks (OR 0.13; p=0.01) was the most important intraoperative factor 
associated with better visual outcomes. Visual outcomes were best 
in the eyes that did not require tamponade and worst in those still 
containing silicone oil at the 6-month acuity evaluation (Table 3).
Discussion
The prevalence of type 2 diabetes in SA increased from 5.5% in 2000 
to 9% in 2009.[4] Current estimates are that 9.7% of the population 
older than 30 years are diabetic[2] and that diabetes causes 8 000 
new cases of blindness annually.[4] Good systemic control of blood 
glucose, hypertension and other risk factors (primary prevention) 
and early detection and management of diabetic retinopathy 
(secondary prevention) are well-established strategies in the battle 
against diabetic blindness. Digital fundus photography screening 
is established in many developed countries, and Khan et al.[2] have 
suggested that this is cost-effective in SA. We are pleased to note the 
recent efforts of Cook and others to highlight and promote screening 
in SA,[5,6] including quality assurance assessment of the graders of 
fundus photographs.[7] Unfortunately there are currently virtually no 
established screening programmes, and patients’ systemic control is 
often poor.[8] In addition, the black African population tends to have 
more aggressive complications of diabetic retinopathy.[9] As a result, 
patients are referred to tertiary institutions with advanced levels of 
pathology requiring surgical intervention.
The most common indication for retinal surgery at GSH is the 
advanced ocular complications of diabetes. Of the patients listed for 
surgery over our study period, 23.4% were blind in both eyes (counting 
fingers or worse) and 20.2% had one eye assessed as inoperable at 
presentation. In addition, the progressive nature of this disease resulted 
in increased morbidity while patients waited for surgery, with 26.2% of 
patients suffering further visual loss during this period.
In our hands, retinal surgery was able to achieve anatomical 
success in 77.1% of cases and visual stability or improvement in 
85.0%, which compares favourably with other series.[10,11] Overall 
visual acuity improved from a mean of 2/60 preoperatively to 6/60 
at 3 months and 6/40 at 6 months. Seventy-four per cent were 
graded as 6/60 or better at 6 months, which is similar to a series of 
174 cases by Yorston et al.[10] Thirty-three per cent achieved 6/12 or 
better, which compares favourably with a more recent series from 
the UK.[11] While Snellen visual acuity is limited in its description 
of visual function, surgery usually achieves stability in an otherwise 
progressive condition. Patients whose vision remains unchanged after 
surgery therefore benefit from the reduced risk of declining visual 
function with time. Our results support vitrectomy as an efficient use 
of resources. Of the 93 cases with 6 months’ follow-up, the number of 
blind eyes (counting fingers or worse) fell from 41 to 24, indicating 
that approximately one in five vitrectomies reverses blindness. 
Yorston et al.[10] published a similar figure of one in seven procedures.
The time between listing for surgery and the operation has been 
found to be an important negative predictor of visual outcomes.[11] 
This is a particularly important factor in resource-limited settings. In 
previous years, the waiting time in our department was longer than 
9 months. With additional theatre time and selection of cases, we 
reduced the waiting time to an average of 2.9 months (range 1 day - 9 
months) at the time of the study. Visual function declined in 26.2% 
of our patients during this period. It is likely that waiting times to 
surgery will continue to be under pressure given the rising prevalence 
of diabetes and limited secondary prevention strategies in place 
in SA. The progressive nature of diabetic retinopathy means that 
prolonged waiting times are also likely to result in more inoperable 
eyes. In addition, delays in removing silicone oil result in higher rates 
of oil-related complications such as raised intraocular pressure.
It is an unfortunate reality that criteria for surgery are often 
changed in order to cope with rising patient numbers. Eyes with 
a more guarded prognosis may not be offered surgery, or surgery 
may only be performed on the eye with the better prognosis. The 
decision whether or not to perform surgery should be based on the 
best available evidence and balanced with available resources. A 
number of researchers have attempted to identify preoperative features 
associated with poor outcome that may be of value in resource-limited 
environments. Apart from delayed surgery, other factors associated 
with poorer outcome include older age at surgery,[12] poor preoperative 
visual acuity,[10,12] poor vision in the other eye at presentation,[10] iris new 
vessels,[12] poor clinic attendance[11] and retinal detachment involving 
the macula,[10] particularly if longstanding.[12] Extensive vitreoretinal 
adhesions are also associated with poorer outcomes,[10] but this finding 
is sometimes only deter mined intraoperatively, making it less useful 
in patient selection for surgery. Unfortunately, many of our patients 
present for the first time with many of these poor prognostic features, 
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Fig. 3. Change in visual acuity from surgery to 6 months (logarithmic scale). 
(CF = count fingers; HM = hand motions; PL/NPL = perception of light/no 
perception of light.)
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making selection of those likely to benefit from surgery more difficult. 
It is helpful to note that systemic factors such as hypertension, previous 
stroke, renal failure and a history of foot ulceration or amputation[10,12] 
should not be criteria for exclusion unless they pose a high anaesthetic 
risk or current risk of infection.
We currently offer surgery for one eye if the patient presents with 
bilateral poor prognostic features. We use the presence of a relative afferent 
pupil defect and ability to identify correctly the position of a light source 
(projection) as important clinical criteria for selection in patients with 
perception of hand motions or light vision only. Many patients presenting 
with unilateral poor-prognosis eyes will only be offered surgery for the eye 
with the better prognosis. Our goal is to benefit the maximum number 
of patients with our current resources. It is important to note that some 
patients with poor prognostic features do well,[10] as was the case in our 
series. This puts additional pressure on the clinician to perform surgery, 
which is not always possible in resource-limited settings.
Study limitations
Our study has a number of limitations. It was a retrospective analysis 
that relied on accurate data entry in case notes. Acuity data at 6 
months were only available for 75% of cases, and best visual acuity 
was based on pinhole testing, as few patients receive refractive 
correction at our hospital. The degree of macular traction was not 
specified and would have ranged from minimal traction to complete 
detachment of the macula, which would have influenced prognosis 
significantly. In addition, we did not grade the degree of cataract and 
assume that visually significant cataracts were operated on. We also 
did not grade the degree of previous laser treatment or vitreoretinal 
attachments, as suggested by Yorston et al.,[10] who found the latter to 
be an important prognostic factor. Despite these limitations we were 
encouraged by the overall success of surgery in our hands.
Preoperative bevacizumab (Avastin) was not used during the study 
period. It has been shown in large studies to reduce surgery time, 
reduce the need for endocautery and decrease the number of iatrogenic 
breaks. [13] We now regularly use bevacizumab (off-label) a few days 
before surgery in eyes with active neovascularisation, which may further 
improve our outcomes. In addition, the introduction of smaller-gauge 
(23- and 25-gauge) instruments and bimanual techniques may be 
associated with fewer posterior iatrogenic breaks.[14] We plan further 
analysis in our hospital as these techniques and technologies are adopted.
Conclusion
This study represents the current retinal surgery practice at our 
centre. The results are in keeping with other publications, and 
are encouraging given our patients’ advanced level of pathology 
at presentation. They provide useful information for patients 
regarding surgical outcomes. We recognise the need to keep 
waiting times for surgery as short as possible, which is likely to 
become more difficult given the diabetes epidemic. Improvement 
in primary and secondary preventive strategies is essential in SA 
and will reduce the number of patients presenting with advanced 
diabetic eye disease.
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